Researchers develop a promising new therapy to tackle metabolic liver disease, NASH
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
Team at the Karl Landsteiner University of Health Sciences in Krems identifies strong correlation between cachexia and markers of bone loss
Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
Findings explain higher risk of heart attack in people with diabetes, even after treatment
The multiplex PCR test is capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases
The High Throughput Tissector (HT) delivers faster, more accurate and efficient tissue dissection
Researchers have discovered that the activation of identified central amygdala neurons can suppress fear responses
Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment
Watch this on-demand to learn how to leverage your spatial analysis with CytoMAP
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies
Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand
Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment
Watch this on-demand webinar to learn how an advanced spatial analysis workflow can be used to analyze the infiltration of CD8 positive cells across the tumor-stroma interface
The new XIENCE Skypoint stent received FDA approval in the U.S. and CE Mark approval in Europe